EPSTI1 Is Involved in IL-28A-Mediated Inhibition of HCV Infection

賴坤詣（2014）。The regulatory and biological functions of IL-32 gene in EBV-infected cells〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2014.03196
Monis, A., Saber, M., & Swaff, R. A. (2014). Impact of Interferon Lambda Gene Polymorphism on Treatment of HCV-4 Infection in Diabetic Patients. Global Journal of Gastroenterology & Hepatology, 2(2), 51-58. https://doi.org/10.12970/2308-6483.2014.02.02.3
Dharancy, S., Lemoine, M., Mathurin, P., Serfaty, L., & Dubuquoy, L. (2009). Peroxisome Proliferator-Activated Receptors in HCV-Related Infection. PPAR Research, 2009(), 56-60. https://doi.org/10.1155/2009/357204
黃于珊、盛望徽（2020）。Advance in the Treatment of HCV Infection in HIV-infected Patients。內科學誌，31(5)，313-317。https://doi.org/10.6314/JIMT.202010_31(5).04
鄭蕙瑩（2012）。The study of human MCPIP1 inhibits hepatitis C virus infection〔碩士論文，臺北醫學大學〕。華藝線上圖書館。https://doi.org/10.6831/TMU.2012.00214